Gene Therapy Global Market Opportunities And Strategies To 2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	305 Pages	The Business Research Company	April, 2023	BRC17888628

Best Price Guarantee
Price	from $5,000
Length	305 Pages
Publisher	The Business Research Company
Published Date	April, 2023
SKU	BRC17888628

Gene Therapy Global Market Opportunities And Strategies To 2032

Gene Therapy Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global gene therapy market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:

Where is the largest and fastest growing market for gene therapy? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider gene therapy market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics

Brief introduction to the segmentations covered in the market, definitions and explanations about the gene therapy market.

Key Trends

Highlights the major trends shaping the global gene therapy market. This section also highlights likely future developments in the market.

Global Market Type and Growth

Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis

Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.

Market Segmentation

Contains the market values (2017-2032) and analysis for each segment by gene therapy type, by vector, by application and by end users in the market.

Regional Market Size and Growth

Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape

Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Key Mergers and Acquisitions

Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies

Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations

This section Includes recommendations for gene therapy providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

Appendix

This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Gene Therapy Type: Germline Therapy; Somatic Cell Therapy

2) By Vector: Viral Vector; Non-Viral Vector

3) By End Users: Biopharmaceutical Companies; Research Institutes; Other End Users

4) By Application: Oncology; Orphan Disease; Knee Osteoarthritis; Neurological Disorders

Companies Mentioned: Novartis AG; F. Hoffmann-La Roche Ltd; Gilead Sciences Inc; Astellas Pharma Inc; Biogen Inc

Countries: Australia, China, India, Indonesia, Japan, South Korea, USA, Brazil, France, Germany, UK, Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; gene therapy indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics: 6.1. General Market Definition; 6.2. Summary; 6.3. Gene Therapy Market Definition And Segmentations; 6.4. Market Segmentation By Gene Therapy Type; 6.4.1. Germline Therapy; 6.4.2. Somatic Cell Therapy; 6.5. Market Segmentation By Vector; 6.5.1. Viral Vector; 6.5.2. Non-Viral Vector; 6.6. Market Segmentation By End Users; 6.6.1. Biopharmaceutical Companies; 6.6.2. Research Institutes; 6.6.3. Other End Users; 6.7. Market Segmentation By Application; 6.7.1. Oncology; 6.7.2. Orphan Disease; 6.7.3. Knee Osteoarthritis; 6.7.4. Neurological Disorders
7. Major Market Trends: 7.1. Growing Investments and Manufacturing Facility Expansion; 7.2. Use Of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology; 7.3. Launch Of Cell And Gene Therapy Platforms; 7.4. Partnerships And Collaborations; 7.5. Rising Focus On Gene Editing; 7.6. Strategic Mergers And Acquisitions
8. Global Market Size and Growth: 8.1. Market Size; 8.2. Historic Market Growth, 2017 – 2022, Value ($ Million); 8.2.1. Market Drivers 2017 – 2022; 8.2.2. Market Restraints 2017 – 2022; 8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 8.3.1. Market Drivers 2022 – 2027; 8.3.2. Market Restraints 2022 – 2027
9. Global Gene Therapy Market Segmentation: 9.1. Global Gene Therapy Market, Segmentation By Gene Therapy Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 9.2. Global Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 9.3. Global Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 9.4. Global Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Gene Therapy Market, Regional and Country Analysis: 10.1. Global Gene Therapy Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 10.2. Global Gene Therapy Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market: 11.1. Summary; 11.2. Market Overview; 11.2.1. Region Information; 11.2.2. Market Information; 11.2.3. Background Information; 11.2.4. Government Initiatives; 11.2.5. Regulations; 11.2.6. Regulatory Bodies; 11.2.7. Major Associations; 11.2.8. Taxes Levied; 11.2.9. Corporate Tax Structure; 11.2.10. Investments; 11.2.11. Major Companies; 11.3. Asia-Pacific Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.4. Asia-Pacific Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.5. Asia-Pacific Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.6. Asia-Pacific Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.7. Asia-Pacific Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.8. Asia-Pacific Gene Therapy Market: Country Analysis; 11.9. China Market; 11.10. Summary; 11.11. Market Overview; 11.11.1. Country Information; 11.11.2. Market Information; 11.11.3. Background Information; 11.11.4. Government Initiatives; 11.11.5. Regulations; 11.11.6. Regulatory Bodies; 11.11.7. Major Associations; 11.11.8. Taxes Levied; 11.11.9. Corporate Tax Structure; 11.11.10. Investments; 11.11.11. Major Companies; 11.12. China Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.13. China Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.14. China Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.15. China Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.16. China Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.17. India Market; 11.18. India Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.19. India Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.20. India Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.21. India Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.22. India Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.23. Japan Market; 11.24. Japan Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.25. Japan Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.26. Japan Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.27. Japan Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.28. Japan Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.29. Australia Market; 11.30. Australia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.31. Australia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.32. Australia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.33. Australia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.34. Australia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.35. Indonesia Market; 11.36. Indonesia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.37. Indonesia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.38. Indonesia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.39. Indonesia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.40. South Korea Market; 11.41. South Korea Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.42. South Korea Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.43. South Korea Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.44. South Korea Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.45. South Korea Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market: 12.1. Summary; 12.2. Market Overview; 12.2.1. Region Information; 12.2.2. Market Information; 12.2.3. Background Information; 12.2.4. Government Initiatives; 12.2.5. Regulations; 12.2.6. Regulatory Bodies; 12.2.7. Major Associations; 12.2.8. Taxes Levied; 12.2.9. Corporate Tax Structure; 12.2.10. Investments; 12.2.11. Major Companies; 12.3. Western Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.4. Western Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.5. Western Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.6. Western Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.7. Western Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.8. Western Europe Gene Therapy Market: Country Analysis; 12.9. UK Market; 12.10. UK Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.11. UK Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.12. UK Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.13. UK Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.14. UK Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.15. Germany Market; 12.16. Germany Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.17. Germany Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.18. Germany Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.19. Germany Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.20. Germany Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.21. France Market; 12.22. France Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.23. France Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.24. France Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.25. France Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.26. France Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market: 13.1. Summary; 13.2. Market Overview; 13.2.1. Region Information; 13.2.2. Market Information; 13.2.3. Background Information; 13.2.4. Government Initiatives; 13.2.5. Regulations; 13.2.6. Regulatory Bodies; 13.2.7. Major Associations; 13.2.8. Taxes Levied; 13.2.9. Corporate Tax Structure; 13.2.10. Investments; 13.2.11. Major Companies; 13.3. Eastern Europe Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 13.4. Eastern Europe Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 13.5. Eastern Europe Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.6. Eastern Europe Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.7. Eastern Europe Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.8. Eastern Europe Gene Therapy Market: Country Analysis; 13.9. Russia Market; 13.10. Russia Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 13.11. Russia Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 13.12. Russia Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.13. Russia Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.14. Russia Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market: 14.1. Summary; 14.2. Market Overview; 14.2.1. Region Information; 14.2.2. Market Information; 14.2.3. Background Information; 14.2.4. Government Initiatives; 14.2.5. Regulations; 14.2.6. Regulatory Bodies; 14.2.7. Major Associations; 14.2.8. Taxes Levied; 14.2.9. Corporate Tax Structure; 14.2.10. Investments; 14.2.11. Major Companies; 14.3. North America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 14.4. North America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 14.5. North America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.6. North America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.7. North America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.8. North America Gene Therapy Market: Country Analysis; 14.9. USA Market; 14.10. Summary; 14.11. Market Overview; 14.11.1. Country Information; 14.11.2. Market Information; 14.11.3. Background Information; 14.11.4. Government Initiatives; 14.11.5. Regulations; 14.11.6. Regulatory Bodies; 14.11.7. Major Associations; 14.11.8. Taxes Levied; 14.11.9. Corporate Tax Structure; 14.11.10. Investments; 14.11.11. Major Companies; 14.12. USA Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 14.13. USA Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 14.14. USA Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.15. USA Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.16. USA Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market: 15.1. Summary; 15.2. Market Overview; 15.2.1. Region Information; 15.2.2. Market Information; 15.2.3. Background Information; 15.2.4. Government Initiatives; 15.2.5. Regulations; 15.2.6. Regulatory Bodies; 15.2.7. Major Associations; 15.2.8. Taxes Levied; 15.2.9. Corporate Tax Structure; 15.2.10. Investments; 15.2.11. Major Companies; 15.3. South America Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 15.4. South America Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 15.5. South America Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.6. South America Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.7. South America Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.8. South America Gene Therapy Market: Country Analysis; 15.9. Brazil Market; 15.10. Brazil Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 15.11. Brazil Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 15.12. Brazil Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.13. Brazil Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.14. Brazil Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market: 16.1. Summary; 16.2. Market Overview; 16.2.1. Region Information; 16.2.2. Market Information; 16.2.3. Background Information; 16.2.4. Government Initiatives; 16.2.5. Regulations; 16.2.6. Regulatory Bodies; 16.2.7. Major Associations; 16.2.8. Taxes Levied; 16.2.9. Corporate Tax Structure; 16.2.10. Investments; 16.2.11. Major Companies; 16.3. Middle East Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 16.4. Middle East Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 16.5. Middle East Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 16.6. Middle East Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 16.7. Middle East Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market: 17.1. Summary; 17.2. Market Overview; 17.2.1. Region Information; 17.2.2. Market Information; 17.2.3. Background Information; 17.2.4. Government Initiatives; 17.2.5. Regulations; 17.2.6. Regulatory Bodies; 17.2.7. Major Associations; 17.2.8. Taxes Levied; 17.2.9. Corporate Tax Structure; 17.2.10. Investments; 17.2.11. Major Companies; 17.3. Africa Gene Therapy Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 17.4. Africa Gene Therapy Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 17.5. Africa Gene Therapy Market, Segmentation By Vector, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 17.6. Africa Gene Therapy Market, Segmentation By End Users, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 17.7. Africa Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles: 18.1. Company Profiles; 18.2. Novartis AG; 18.2.1. Company Overview; 18.2.2. Products And Services; 18.2.3. Business Strategy; 18.2.4. Financial Overview; 18.3. F. Hoffmann-La Roche AG; 18.3.1. Company Overview; 18.3.2. Products And Services; 18.3.3. Business Strategy; 18.3.4. Financial Overview; 18.4. Gilead Sciences Inc.; 18.4.1. Company Overview; 18.4.2. Products And Services; 18.4.3. Financial Overview; 18.5. Astellas Pharma Inc.; 18.5.1. Company Overview; 18.5.2. Products And Services; 18.5.3. Business Strategy; 18.5.4. Financial Overview; 18.6. Biogen Inc.; 18.6.1. Company Overview; 18.6.2. Products And Services; 18.6.3. Business Strategy; 18.6.4. Financial Overview
19. Key Mergers And Acquisitions: 19.1. Rocket Pharmaceuticals Acquired Renovacor; 19.2. Eli Lilly Acquired Akouos; 19.3. Ginkgo Bioworks Acquired Altar and Circularis; 19.4. Solvias Acquired Cergentis; 19.5. Novartis Acquired Gyroscope Therapeutics; 19.6. FHI Clinical Acquired Triclinium Clinical Development; 19.7. WuXi AppTec Acquired OXGENE
20. Pipeline Analysis: 20.1. Products In Development; 20.2. Approved Products
21. Opportunities And Strategies: 21.1. Global Gene Therapy Market In 2027 – Countries Offering Most New Opportunities; 21.2. Global Gene Therapy Market In 2027 – Segments Offering Most New Opportunities; 21.3. Global Gene Therapy Market In 2027 – Growth Strategies; 21.3.1. Market Trend Based Strategies; 21.3.2. Competitor Strategies
22. Gene Therapy Market, Conclusions And Recommendations: 22.1. Conclusions; 22.2. Recommendations; 22.2.1. Product; 22.2.2. Place; 22.2.3. Price; 22.2.4. Promotion; 22.2.5. People
23. Appendix: 23.1. Market Data Sources; 23.2. Research Methodology; 23.3. Currencies; 23.4. The Business Research Company; 23.5. Copyright and Disclaimer